Profile
Full Name
Janux Therapeutics, Inc.Ticker Symbol
JANXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 11, 2021Indexes
Not includedWebsite
http://www.januxrx.comEmployees
81Key Details
Price
$29.69(+3.49%)
Market cap
$1.75B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$10.59M(+30.99% YoY)
Annual EPS
-$1.28(+3.03% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Janux Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 3, 25 HC Wainwright & Co.
BuyFeb 28, 25 Scotiabank
Sector PerformDec 11, 24 Cantor Fitzgerald
OverweightDec 4, 24 Scotiabank
Sector PerformDec 3, 24 Stifel
BuyDec 3, 24 Leerink Partners
OutperformDec 3, 24 HC Wainwright & Co.
BuyNov 22, 24 Leerink Partners
OutperformNov 7, 24 HC Wainwright & Co.
BuyNov 7, 24 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for Janux Therapeutics?
- Does Janux Therapeutics pay dividends?
- What sector is Janux Therapeutics in?
- What industry is Janux Therapeutics in?
- What country is Janux Therapeutics based in?
- When did Janux Therapeutics go public?
- Is Janux Therapeutics in the S&P 500?
- Is Janux Therapeutics in the NASDAQ 100?
- Is Janux Therapeutics in the Dow Jones?
- When was Janux Therapeutics's last earnings report?
- When does Janux Therapeutics report earnings?
- Should I buy Janux Therapeutics stock now?
What is the ticker symbol for Janux Therapeutics?
The ticker symbol for Janux Therapeutics is NASDAQ:JANX
Does Janux Therapeutics pay dividends?
No, Janux Therapeutics does not pay dividends
What sector is Janux Therapeutics in?
Janux Therapeutics is in the Healthcare sector
What industry is Janux Therapeutics in?
Janux Therapeutics is in the Biotechnology industry
What country is Janux Therapeutics based in?
Janux Therapeutics is headquartered in United States
When did Janux Therapeutics go public?
Janux Therapeutics's initial public offering (IPO) was on June 11, 2021
Is Janux Therapeutics in the S&P 500?
No, Janux Therapeutics is not included in the S&P 500 index
Is Janux Therapeutics in the NASDAQ 100?
No, Janux Therapeutics is not included in the NASDAQ 100 index
Is Janux Therapeutics in the Dow Jones?
No, Janux Therapeutics is not included in the Dow Jones index
When was Janux Therapeutics's last earnings report?
Janux Therapeutics's most recent earnings report was on Nov 6, 2024
When does Janux Therapeutics report earnings?
The next expected earnings date for Janux Therapeutics is May 8, 2025
Should I buy Janux Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions